Vrati se na sadržaj

Akušerstvo

Lečenje trombocitopenije

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (otvara novi prozor)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Izvor‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indeks‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (otvara novi prozor)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (otvara novi prozor)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Izvor‎: Blood 2020;136(26):3056-61.

Indeks‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (otvara novi prozor)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (otvara novi prozor)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Izvor‎: Asian J Transfus Sci 2016;10(2):155-8.

Indeks‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (otvara novi prozor)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (otvara novi prozor)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Izvor‎: Blood 2013;121(3):537-45.

Indeks‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (otvara novi prozor)